2021•International Journal of PharmaceuticsOpen access

Continuous manufacture of hydroxychloroquine sulfate drug products via hot melt extrusion technology to meet increased demand during a global pandemic: From bench to pilot scale

Victoire de Margerie, Christopher F. McConville, Suha Dadou, Shu Li, Pascal Boulet, Lionel Aranda, Andrew Walker, Valentyn Mohylyuk, David S. Jones, Brian M. Murray, Gavin P. Andrews

Open full text 13 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Plastics extrusion, SCALE-UP, Crystallinity, Extrusion, Materials science, Process engineering, Pharmaceutical manufacturing, Environmental science

Related papers

Back to paper searchBrowse research topicsOriginal source
Continuous manufacture of hydroxychloroquine sulfate drug products via hot melt extrusion technology to meet increased demand during a global pandemic: From bench to pilot scale — Research Paper | ScholarLens